BeStock  
Markets › Compare › JAZZ vs INCY

JAZZ vs INCY

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
JAZZ · Jazz Pharmaceuticals$233.37 ▲ 0.80%
INCY · Incyte$118.78 ▼ 2.12%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

90117143170196Oct 2, '25Apr 1, '26Sep 30, '26
  • JAZZ +68.7%
  • INCY +40.6%

Head to head

MetricJAZZINCY
Price$233.37$118.78
Change today▲ 0.80%▼ 2.12%
Market cap$15.15B$24.08B
Return, 3 months-1.7%+4.4%
Return, year to date+37.3%+20.3%
Return, 1 year+70.5%+37.0%
P/E (TTM)16.015.1
P/B3.23.8
P/E percentile vs own 5y63rd7th
Dividend yield––
Revenue growth (YoY, latest qtr)+15.5%+37.7%
Net profit growth (YoY)+126.8%+44.6%
Gross margin88.4%92.6%
Operating margin22.1%31.6%
Net margin20.4%27.7%
Return on equity22.1%30.7%
Analyst target vs. price+29.9%+18.4%
Analyst buy share100%79%
RSI (14)3644
30-day volatility27.0%26.3%
Max drawdown, 1 year-11.5%-18.3%
Trend readLeaning bearishLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • INCY is the largest of the group by market value.
  • JAZZ has returned the most over the past year.
  • INCY carries the lowest trailing P/E.
  • INCY is growing revenue fastest.
  • INCY keeps the most profit per dollar of sales.
  • INCY has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top